Matches in Wikidata for { <http://www.wikidata.org/entity/Q66405313> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q66405313 description "clinical trial" @default.
- Q66405313 description "ensayu clínicu" @default.
- Q66405313 description "клінічне випробування" @default.
- Q66405313 name "A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer" @default.
- Q66405313 type Item @default.
- Q66405313 label "A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer" @default.
- Q66405313 prefLabel "A Study of Abemaciclib (LY2835219) Plus Tamoxifen or Abemaciclib Alone in Women With Metastatic Breast Cancer" @default.
- Q66405313 P1132 Q66405313-7A604AB6-3D56-4ADC-8AA5-694E047B816F @default.
- Q66405313 P1476 Q66405313-C28D8416-051A-42CA-8BDE-15B6DABD98BF @default.
- Q66405313 P17 Q66405313-0F7C9C3D-AC32-484F-AC8C-0F6BE894B170 @default.
- Q66405313 P17 Q66405313-21999063-E85B-4596-8ED7-FCAE0D05AF75 @default.
- Q66405313 P17 Q66405313-37448E7F-07F0-4E97-A4BF-01CD345BAEEA @default.
- Q66405313 P17 Q66405313-42153237-D02B-416E-A940-6127FAF69F41 @default.
- Q66405313 P17 Q66405313-4BD940D5-5DF7-4040-B9E8-E177CCC10388 @default.
- Q66405313 P17 Q66405313-5E21959A-8935-4DD6-B9CE-319AE19C308A @default.
- Q66405313 P17 Q66405313-647393F9-53A4-4BCA-BA42-C2091A8B6B25 @default.
- Q66405313 P17 Q66405313-75B3E1E2-5DC7-4FAA-942D-D9B2CC5282C3 @default.
- Q66405313 P17 Q66405313-8688E307-A678-49A2-BFBE-38701B81F672 @default.
- Q66405313 P17 Q66405313-D9D6462D-D9F0-4619-A3FB-59C7E5F8F8F9 @default.
- Q66405313 P17 Q66405313-DC1F03B3-D14A-42C0-A106-E616B6A73FFA @default.
- Q66405313 P17 Q66405313-E9F614E4-F364-4C83-94EB-383BC5418EE2 @default.
- Q66405313 P1813 Q66405313-81BD9B6F-4921-4588-BC93-E5E86AF1A673 @default.
- Q66405313 P2899 Q66405313-C94E7CFD-81FE-48D3-9380-229E6FB8C8BE @default.
- Q66405313 P3098 Q66405313-2044AEF3-14C3-4886-8E2B-06EB4204FA91 @default.
- Q66405313 P31 Q66405313-28AC889C-8D3E-494B-B2F2-243261197A6E @default.
- Q66405313 P4844 Q66405313-523B2B81-541E-4B47-B97E-4DDE3D624A3B @default.
- Q66405313 P4844 Q66405313-6DAB52B6-4C0F-4D06-8516-CCEB53B7DEDE @default.
- Q66405313 P580 Q66405313-12518073-E19F-4415-BB89-AA6D48A6E00D @default.
- Q66405313 P582 Q66405313-49BD6EF8-ECFD-4D22-BFAD-12EAC618E51D @default.
- Q66405313 P6099 Q66405313-A36FEEB0-0FA4-4FDD-B07C-B678E6CFB4B4 @default.
- Q66405313 P8363 Q66405313-28375EC5-0007-4302-8ADE-763C754BB5EC @default.
- Q66405313 P1132 "+234" @default.
- Q66405313 P1476 "A Randomized, Open-Label, Phase 2 Study of Abemaciclib Plus Tamoxifen or Abemaciclib Alone, in Women With Previously Treated Hormone Receptor-Positive, HER2-Negative, Metastatic Breast Cancer" @default.
- Q66405313 P17 Q142 @default.
- Q66405313 P17 Q155 @default.
- Q66405313 P17 Q183 @default.
- Q66405313 P17 Q29 @default.
- Q66405313 P17 Q30 @default.
- Q66405313 P17 Q31 @default.
- Q66405313 P17 Q38 @default.
- Q66405313 P17 Q40 @default.
- Q66405313 P17 Q414 @default.
- Q66405313 P17 Q43 @default.
- Q66405313 P17 Q865 @default.
- Q66405313 P17 Q96 @default.
- Q66405313 P1813 "Next MONARCH 1" @default.
- Q66405313 P2899 "+18" @default.
- Q66405313 P3098 "NCT02747004" @default.
- Q66405313 P31 Q30612 @default.
- Q66405313 P4844 Q412178 @default.
- Q66405313 P4844 Q423751 @default.
- Q66405313 P580 "2016-09-14T00:00:00Z" @default.
- Q66405313 P582 "2018-06-15T00:00:00Z" @default.
- Q66405313 P6099 Q42824440 @default.
- Q66405313 P8363 Q78089383 @default.